Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Recruiting now refers to the overall study. Local openings are shown only when the registry lists an open site.
This study evaluates the safety and effectiveness of DT-101 for people with depression.
This study evaluates the safety and effectiveness of DT-101 for people with depression.
A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Read the official source — NCT07140913Researchers compare KarXT with placebo, each added to lithium, valproate or lamotrigine, in people with bipolarity type I experiencing mania, with or without mixed features. They want to know whether adding KarXT improves manic symptoms and assess its safety.
This study evaluates the safety and effectiveness of Esketamine for people with depression.
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Read the official source — NCT06951698Researchers compare KarXT with placebo to find out whether it reduces manic symptoms in people with bipolarity type I. They also assess side effects and safety during treatment.
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Read the official source — NCT06951711Researchers compare KarXT with placebo during a three-week hospital treatment period for people with bipolarity type I experiencing mania, with or without mixed features. They assess changes in manic symptoms and monitor safety.
Researchers are comparing KarXT and placebo to find out how the approaches affect psychotic symptoms in young people with schizophrenia.
Researchers are comparing SPT-300 and placebo to find out how the approaches affect depression symptoms in adults with depression.
A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms
A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride in Children and Adolescents With Psychiatric Disorders
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.